Original title: Analýza adherence pacientů k léčbě DOAC I
Translated title: Analysis of patient adherence to treatment by DOAC I
Authors: Rezáková, Katarína ; Malý, Josef (advisor) ; Smejkalová, Lenka (referee)
Document type: Master’s theses
Year: 2023
Language: slo
Abstract: [eng] [cze]
Analysis of patient adherence to treatment by DOAC I Author: Katarína Rezáková Tutor: doc. PharmDr. Josef Malý, Ph.D. Consultant: PharmDr. Kateřina Malá, Ph.D. Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University Introduction and aims: Atrial fibrillation (AF) is the most common supraventricular tachyarrhythmia associated with increased morbidity and mortality. In clinical practice, direct oral anticoagulants (DOAC) are used as an alternative to warfarin to prevent thromboembolic events in patients with AF. The study aimed to analyse the statements of patients with FiP along with data from medical records focusing on aspects related to the use and management of DOAC, including devices and tools to improve adherence to treatment, patients' level of awareness of DOAC and other therapeutic agents used. Methods: The prospective study was conducted from 2020 to 2022 at the University Hospital Brno. Patients aged ≥ 18 years with AF on DOAC therapy (dabigatran, rivaroxaban and apixaban) were included in the study. Data about pharmacotherapy and patients' health status were obtained from medical records and structured interview with the patient. Patients' interviews were performed at time 0, three and six months after patient has entred the study.... Analýza adherencie pacientov na liečbu DOAC I Autor: Katarína Rezáková Vedúci diplomovej práce: doc. PharmDr. Josef Malý, Ph.D. Konzultant: PharmDr. Kateřina Malá, Ph.D. Katedra sociálnej a klinickej farmácie, Farmaceutická fakulta v Hradci Králové, Univerzita Karlova Úvod a cieľ: Fibrilácia predsiení (FiP) je najčastejšia supraventrikulárna tachyarytmia spojená s vyššou morbiditou a mortalitou. V klinickej praxi sa používajú priame perorálne antikoagulanciá (DOAC) ako alternatíva k warfarínu na prevenciu tromboembolických príhod u pacientov s FiP. Cieľom tejto práce bolo analyzovať výpovede pacientov s FiP doplnené o dáta zo zdravotníckej dokumentácie s dôrazom na aspekty spojené s užívaním a zaobchádzaním s DOAC vrátane prostriedkov a nástrojov na podporu adherencie k liečbe, ďalej na mieru informovanosti pacientov týkajúcu sa DOAC a ostatné užívané terapeutické prostriedky. Metodika: Prospektívna štúdia prebiehala od roku 2020 do 2022 vo Fakultnej nemocnici Brno. V štúdii boli zahrnutí pacienti vo veku ≥ 18 rokov s FiP na terapii DOAC (dabigatran, rivaroxaban a apixaban). Dáta o farmakoterapii a zdravotnom stave pacientov boli získané zo zdravotníckej dokumentácie a zo štruktúrovaného rozhovoru s pacientom. Rozhovory s pacientami boli vedené v čase 0, tri a šesť mesiacov od vstupu pacienta do...
Keywords: atrial fibrillation; DOAC; Patient adherence; Adherence k léčbě; DOAC; fibrilace síní

Institution: Charles University Faculties (theses) (web)
Document availability information: Available in the Charles University Digital Repository.
Original record: http://hdl.handle.net/20.500.11956/186333

Permalink: http://www.nusl.cz/ntk/nusl-536236


The record appears in these collections:
Universities and colleges > Public universities > Charles University > Charles University Faculties (theses)
Academic theses (ETDs) > Master’s theses